# Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination

> **NCT02064504** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK961081
- **DRUG:** Fluticasone furoate

## Key facts

- **NCT ID:** NCT02064504
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-19
- **Primary completion:** 2014-05-20
- **Final completion:** 2014-05-20
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02064504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02064504, "Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02064504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*